<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="162333">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00985205</url>
  </required_header>
  <id_info>
    <org_study_id>RE-ENERGIZE</org_study_id>
    <secondary_id>CIHR # 190808</secondary_id>
    <nct_id>NCT00985205</nct_id>
  </id_info>
  <brief_title>The RE-ENERGIZE Study: RandomizEd Trial of ENtERal Glutamine to minimIZE Thermal Injury</brief_title>
  <acronym>RE-ENERGIZE</acronym>
  <official_title>Effects of Enteral Glutamine Supplementation on Mortality and Infectious Morbidity in Severely Burned Patients: a Multi-center Pilot Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Daren K. Heyland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Institutes of Health Research (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Clinical Evaluation Research Unit at Kingston General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test the following hypotheses:

        1. Enteral glutamine administration decreases in-hospital mortality in adult subjects with
           severe thermal burn injuries.

        2. Enteral glutamine administration decreases infectious morbidity and shortens length of
           care in adult subjects with severe thermal burn injuries.

        3. Enteral glutamine administration decreases the cost of care of adult subjects with
           severe thermal burn injuries.

      The objectives of this proposed pilot trial relate to evaluating the feasibility of the
      study protocol. Specifically, the investigators want to assess the following outcomes in a
      sample of 200 patients in 8 sites:

        1. Number of patients enrolled per site per month and reasons for non-enrollment.

        2. Rate of consent for eligible patients.

        3. Rate of adherence to study interventions and reasons for non-adherence
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Enteral glutamine has been found to decrease mortality in critically ill patients and blood
      infection in trauma patients. In our pilot study (Critical Care Medicine, 2003, 31:2444) we
      found the same protective effect of glutamine against blood infection in severely burned
      adult patients. In addition, a significant decrease in mortality was observed with
      glutamine. These results should be tested with a multi-center trial because our study was
      small and did not have mortality as an end point. Since such a large multi center study has
      never been conducted in burn patients, a pilot study that will test its feasibility seems
      warranted.

      The mechanism of action of glutamine is controversial. Improvement in T cell immune
      functions, anti-oxidant properties and a newly discovered action on heat shock proteins
      could all be involved. If our clinical hypothesis is supported by the results of this trial,
      additional grant proposals will be made to test several mechanistic hypotheses, using blood
      samples obtained from a randomly determined sub-group of patients stratified for severity of
      the injury.

      The specific aims of the pilot study will be to determine recruitment rates, compliance with
      nutritional burn management protocol and with study intervention. Clinical outcomes will be:
      mortality, incidence of infectious episodes, clinical status during the ICU stay and length
      of care in adult with severe burns.

      The study will be a multi-center, prospective, double blinded, and controlled randomised
      clinical trial. Randomization will be concealed and stratified for burn severity. Patients
      will be adults, a minimum of 18 years old, admitted within 48h post burn, with deep 2nd
      and/or 3rd degree burns requiring grafting, and for patients age 18 - 59 years a (Total Burn
      Surface Area) TBSA ≥ 20% or in the presence of an inhalation injury a minimum of 15% TBSA is
      required; for patients aged 60 years or older a TBSA ≥ 10% is required. The pilot study will
      include approximately 8 burn centers, 2 in Canada and 6 in the US and enrol 200 patients
      over four years. These patients will be included in the final analysis of the complete
      trial. Compliance with study protocols and with study intervention will be assessed through
      regular on site visits, regular phone contacts and teleconferences.

      Glutamine or a placebo will be given every 6 hours at 0.5 gm/kg/day as boluses or orally,
      until 7 days post last successful graft, discharge from the burn unit, or 6 months from ICU
      admission, whatever comes first. Resuscitation, nutritional support, pain management,
      infection control and surgical care will be done according to standardized procedures.

      Participating sites that choose to collect labs for the mechanistic studies will collect
      approximately 30 mls (2 Tablespoons) of blood on days 4, 7, 14 and 21 to test the effect of
      glutamine on inflammatory response and the time-course of inflammation, immunosuppression
      and the production of heat shock proteins Samples will be drawn on CPT tubes for white blood
      cells isolation.

      The end points of the study are: Primary: Recruitment rates, Compliance with study protocols
      and compliance with study intervention. Secondary: mortality, incidence of infectious
      episodes, ICU length of care, length of care, and multiple organ functions. The
      cost-effectiveness of glutamine administration will also be measured if the results show a
      decrease in length of care or a reduced incidence of infections with glutamine. These
      outcomes will be measured but not analysed during this pilot trial.

      The Data will be collected and managed by a professional and centralized organization for
      multi centres clinical research (Clinical Evaluation Research Unit, Kingston, Ontario,
      Canada).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hospital mortality</measure>
    <time_frame>7 days after last grafting procedure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>6 month mortality</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of infections</measure>
    <time_frame>10 days after last grafting procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Care</measure>
    <time_frame>7 days after last grafting procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of mechanical ventilation</measure>
    <time_frame>Number of days on ventilator up to 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of ICU stay</measure>
    <time_frame>All days with assisted ventilation up to 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SOFA Score</measure>
    <time_frame>Daily while mechanically ventilated up to 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>APACHE II Score</measure>
    <time_frame>Once - calculated per data from the first 24 hours of ICU admission</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2700</enrollment>
  <condition>Burns</condition>
  <arm_group>
    <arm_group_label>Enteral Glutamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.5 gm/kg/day mixed in water and given via nasogastric tube as boluses q 4 hrs or TID if po</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Mixed in with water and given via nasogastric tube as boluses q 4hrs or TID if po</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Enteral Glutamine</intervention_name>
    <description>0.5g/kg/day powdered glutamine to be mixed in with water and given via nasogastric tube q4 hrs or TID if po.</description>
    <arm_group_label>Enteral Glutamine</arm_group_label>
    <other_name>Glutamine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Maltodextrin mixed with water given via NG tube Q 4 hours or TID if po.</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Maltodextrin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Deep 2nd and/or 3rd degree burns requiring grafting

          2. a.) Patients 18 - 59 years of age without inhalation injury TBSA* ≥ 20% b.) Patients
             18 - 59 years of age with inhalation injury TBSA* ≥ 15% c.) Patients ≥ 60 years of
             age (with or without inhalation injury) TBSA* ≥ 10%

               -  TBSA - Total Burn Surface Area

        Exclusion Criteria:

          1. &gt; 72 hrs from admission to ICU to time of consent.

          2. Patients younger than 18 years of age

          3. In patients without known renal disease, renal dysfunction defined as a serum
             creatinine &gt;171 µmol/L or a urine output of less than 500 ml/last 24 hours (or 80
             ml/last 4 hours if a 24 hour period of observation is not available). In patients
             with acute on chronic renal failure (pre-dialysis), an absolute increase of &gt;80
             µmol/L from baseline or pre-admission creatinine or a urine output of &lt;500 ml/last 24
             hours (or 80 ml/last 4 hours) will be required. Patients with chronic renal failure
             on dialysis will be excluded.

          4. Liver cirrhosis - Child's class C liver disease

          5. Pregnancy

          6. Absolute contra-indication for EN: intestinal occlusion or perforation, abdominal
             injury

          7. Patients with injuries from high voltage electrical shock

          8. Patients who are moribund

          9. Patients with extreme body sizes: BMI &lt; 18 or &gt; 50

         10. Enrolment in another industry sponsored ICU intervention study

         11. Received glutamine supplement for &gt; 24 hrs prior to randomization

         12. Known allergy to maltodextrin, corn starch, corn, corn products or glutamine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daren Heyland, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Queen's University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maureen Dansereau</last_name>
    <phone>613 549 6666</phone>
    <phone_ext>6686</phone_ext>
    <email>danserem@kgh.kari.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Daren Heyland, MD</last_name>
    <email>dkh2@queensu.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Arizona Burn Center at Maricopa Medical Center</name>
      <address>
        <city>Pheonix</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kevin Foster</last_name>
      <email>kevin_foster@dmgaz.org</email>
    </contact>
    <investigator>
      <last_name>Kevin Foster</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southern California Regional Burn Ctr at LAC &amp; USC Med. Ctr.</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Warren Garner</last_name>
      <email>garner@surgery.usc.edu</email>
    </contact>
    <investigator>
      <last_name>Warren Garner</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California San Diego Regional Burn Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bruce Potenza</last_name>
      <email>bpotenza@ucsd.edu</email>
    </contact>
    <investigator>
      <last_name>Bruce Potenza</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Santa Clara Valley Medical Center Regional Burn Center</name>
      <address>
        <city>San Hose</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yvnonne Karanas</last_name>
      <email>yvonne.karanas@hhs.sccgov.org</email>
    </contact>
    <investigator>
      <last_name>Yvonne Karanas</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Grossman Burn Center</name>
      <address>
        <city>West Hills</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Peter Grossman</last_name>
      <email>phg@grossmanmed.com</email>
    </contact>
    <investigator>
      <last_name>Peter Grossman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Anesthesiology, University of Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Wischmeyer, MD</last_name>
      <phone>720-848-6745</phone>
      <email>paul.wischmeyer@ucdenver.edu</email>
    </contact>
    <investigator>
      <last_name>Paul Wischmeyer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Connecticut Burn Center</name>
      <address>
        <city>Bridgeport</city>
        <state>Connecticut</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alisa Salvetamel</last_name>
      <email>alisa.savetamal@bpthosp.org</email>
    </contact>
    <investigator>
      <last_name>Alisa Salvetamel</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stands Burn Center at the University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Mozingo</last_name>
      <email>mozindw@surgery.ufl.edu</email>
    </contact>
    <investigator>
      <last_name>David Mozingo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Miami, Jackson Memorial Burn Center</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Louis Pizano</last_name>
      <email>lpizano@med.miami.edu</email>
    </contact>
    <investigator>
      <last_name>Louis Pizano</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of South Florida/Tampa Gen. Hosp. Reg. Burn Center, FL</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David Smith</last_name>
      <email>dsmith3@health.usf.edu</email>
    </contact>
    <investigator>
      <last_name>David Smith</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Joseph M Still Burn Center</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30909</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruce Friedman, MD</last_name>
      <phone>706-364-2966</phone>
      <email>pmcdade@acutecareconsultants.net</email>
    </contact>
    <contact_backup>
      <last_name>M. Anwarhul H Mian, MD, PhD, MPH</last_name>
      <phone>706-364-2966</phone>
      <email>Mah.Mian@jmsburncenters.com</email>
    </contact_backup>
    <investigator>
      <last_name>Bruce Friedman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Summer L. Hosh Burn Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stathis Poulakidas</last_name>
      <email>spoulacdoc1@msn.com</email>
    </contact>
    <investigator>
      <last_name>Stathis Poulaskidas</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Chicago Burn Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lawrence Gottlieb</last_name>
      <email>lgottlie@surgery.bds.uchicago.edu</email>
    </contact>
    <investigator>
      <last_name>Lawrence Gottlieb</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Surgery University of Iowa Hospitals &amp; Clinics</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucy Wibbenmeyer, MD</last_name>
      <phone>319-353-8435</phone>
      <email>Lucy-wibbenmeyer@uiowa.edu</email>
    </contact>
    <investigator>
      <last_name>Lucy Wibbenmeyer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of Kansas Hospital/The Burnett Burn Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>James Howard</last_name>
      <email>jhoward3@kumc.edu</email>
    </contact>
    <investigator>
      <last_name>James Howard</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>John Hopkins Burn Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Julie Caffrey</last_name>
      <email>jcaffre5@jhmi.edu</email>
    </contact>
    <investigator>
      <last_name>Julie Caffrey</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital Burn Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stephanie Nitzschke</last_name>
      <email>SNITZSCHKE@PARTNERS.ORG</email>
    </contact>
    <investigator>
      <last_name>Stephanie Nitzschke</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jeremy Goverman</last_name>
      <email>JGOVERMAN@mgh.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Jeremy Goverman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spectrum Health Regional Burn Center</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Richard Wilcox</last_name>
      <email>richard.wilcox@spectrumhealth.org</email>
    </contact>
    <investigator>
      <last_name>Richard Wilcox</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mercy Hospital St. Louis</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63141</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonathan Pollack, MD</last_name>
      <phone>314-251-5570</phone>
      <email>jonathan.pollack@mercy.net</email>
    </contact>
    <contact_backup>
      <last_name>Mary Wilcox, RN, BSN</last_name>
      <phone>314-251-7899</phone>
      <email>mary.wilcox@mercy.net</email>
    </contact_backup>
    <investigator>
      <last_name>Jonathan Pollack, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Smock, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Elizabeth Regional Burn Center</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Voigt</last_name>
      <email>dwvoigt@neb.rr.com</email>
    </contact>
    <investigator>
      <last_name>David Voigt</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jessica Summers</last_name>
      <email>jessica.summers@unmc.edu</email>
    </contact>
    <investigator>
      <last_name>Jessica Summers</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Debra Reilly</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cornell University</name>
      <address>
        <city>Ithaca</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Palmer &quot;Joe&quot; Q Bessey</last_name>
      <email>pqb2001@med.cornell.edu</email>
    </contact>
    <investigator>
      <last_name>Palmer &quot;Joe&quot; Q Bessey</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SUNY Upstate University Hospital, Clark Burn</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Joan Dolinak</last_name>
      <email>dolinakj@upstate.edu</email>
    </contact>
    <investigator>
      <last_name>Joan Dolinak</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wake Forest University Health Sciences</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Homes</last_name>
      <email>homes@wakehealth.edu</email>
    </contact>
    <investigator>
      <last_name>James Homes</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Akron's Children's Hospital, Paul &amp; Carol David Foundation</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>John Crow</last_name>
      <email>Jcrow@chmca.org</email>
    </contact>
    <investigator>
      <last_name>John Crow</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MetroHeath Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anjay Khandelwal</last_name>
      <email>akhandelwal@metrohealth.org</email>
    </contact>
    <investigator>
      <last_name>Anjay Khandelwal</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Ohio State University Wexnar Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Larry Jones</last_name>
      <email>larry.jones@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>Larry Jones</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Legacy Emmanuel Hospital &amp; Health Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathan A Kemalyan, MD</last_name>
      <phone>503-413-4232</phone>
      <email>NKemalya@lhs.org</email>
    </contact>
    <investigator>
      <last_name>Nathan A Kemalyan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Western Pennsylvania Hospital Burn Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ariel Abbalay</last_name>
      <email>aaballay@wpahs.org</email>
    </contact>
    <investigator>
      <last_name>Ariel Aballay</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nathan Speare Regional Burn Treatment Centre</name>
      <address>
        <city>Upland</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Linwood Haith</last_name>
      <email>LOPOB50@aol.com</email>
    </contact>
    <investigator>
      <last_name>Linwood Haith</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of Tennessee Health Science Center</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>TG032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Hickerson</last_name>
      <phone>901-448-2579</phone>
      <email>whicker1@uthsc.edu</email>
    </contact>
    <investigator>
      <last_name>William Hickerson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Steven Wolf</last_name>
      <email>steven.wolf@utsouthwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Steven Wolf</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Medical Branch</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David Herndon</last_name>
      <email>dherndon@UTMB.EDU</email>
    </contact>
    <investigator>
      <last_name>David Herndon</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Memorial Hermann/UTHSC</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>James Cross</last_name>
      <email>James.M.Cross@uth.tmc.edu</email>
    </contact>
    <investigator>
      <last_name>James Cross</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah Burn Center</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stephen Morris</last_name>
      <email>stephen.morris@utah.edu</email>
    </contact>
    <investigator>
      <last_name>Stephen Morris</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Burn Center at Washington Hospital Center</name>
      <address>
        <city>D.c.</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jefferey Shupp</last_name>
      <email>Jeffery.W.Shupp@medstar.net</email>
    </contact>
    <investigator>
      <last_name>Jeffery Shupp</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Harbourview Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sam Mandell</last_name>
      <email>mantels@uw.edu</email>
    </contact>
    <investigator>
      <last_name>Sam Mandell</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia St. Mary's</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicholas Meyer</last_name>
      <email>nicholas.meyer@columbia-stmarys.org</email>
    </contact>
    <investigator>
      <last_name>Nicholas Meyer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia-St. Mary's, Milwaukee, Wi</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicholas Meyer</last_name>
      <email>meyernamu@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Nicholas Meyer</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Calgary Firefighters' Burn Unit</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tom Stelfox</last_name>
      <email>tstelfox@ucalgary.ca</email>
    </contact>
    <investigator>
      <last_name>Tom Stelfox</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Firefighters' Burn Treatment Unit Plastic Surgery Wound Healing Research Laboratory</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 2B7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edward E Tredget, MD, MSc</last_name>
      <phone>780-407-6979</phone>
      <phone_ext>407</phone_ext>
      <email>tracey.dean@albertahealthservices.ca</email>
    </contact>
    <investigator>
      <last_name>Edward E Tredget, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vancouver General Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Henderson</last_name>
      <email>willliam.Henderson@vch.ca</email>
    </contact>
    <investigator>
      <last_name>William Henderson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Health Sciences Centre Burn Unit, Winnipeg</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sarvesh Logsetty</last_name>
      <email>logsetty@cc.umanitoba.ca</email>
    </contact>
    <investigator>
      <last_name>Sarvesh Logsetty</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HHS/Hamilton Firefighters Burn Unit</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Arianna Dal Cin</last_name>
      <email>dalcin@hhsc.ca</email>
    </contact>
    <investigator>
      <last_name>Ariana Dal Cin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ross Tilley Burn Centre, Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4N 3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Jeschke, MD</last_name>
      <phone>416-480-6703</phone>
      <email>marc.jeschke@sunnybrook.ca</email>
    </contact>
    <investigator>
      <last_name>Marc Jeschke, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHUM/Centre des Grands Brules</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sylvain Belisle</last_name>
      <email>Sylvain.Belisle@sympatico.ca</email>
    </contact>
    <investigator>
      <last_name>Sylvain Belisle</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HEJ/Centre des Grands Brules</name>
      <address>
        <city>Quebec</city>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexis Turgeon</last_name>
      <email>alexis.turgeon@fmed.ulaval.ca</email>
    </contact>
    <investigator>
      <last_name>Alexis Turgeon</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Australia</country>
  </removed_countries>
  <link>
    <url>http://www.criticalcarenutrition.com</url>
    <description>Related Info</description>
  </link>
  <reference>
    <citation>Garrel D, Patenaude J, Nedelec B, Samson L, Dorais J, Champoux J, D'Elia M, Bernier J. Decreased mortality and infectious morbidity in adult burn patients given enteral glutamine supplements: a prospective, controlled, randomized clinical trial. Crit Care Med. 2003 Oct;31(10):2444-9.</citation>
    <PMID>14530749</PMID>
  </reference>
  <reference>
    <citation>Zhou YP, Jiang ZM, Sun YH, Wang XR, Ma EL, Wilmore D. The effect of supplemental enteral glutamine on plasma levels, gut function, and outcome in severe burns: a randomized, double-blind, controlled clinical trial. JPEN J Parenter Enteral Nutr. 2003 Jul-Aug;27(4):241-5.</citation>
    <PMID>12903886</PMID>
  </reference>
  <reference>
    <citation>Peng X, Yan H, You Z, Wang P, Wang S. Effects of enteral supplementation with glutamine granules on intestinal mucosal barrier function in severe burned patients. Burns. 2004 Mar;30(2):135-9.</citation>
    <PMID>15019120</PMID>
  </reference>
  <verification_date>September 2016</verification_date>
  <lastchanged_date>September 6, 2016</lastchanged_date>
  <firstreceived_date>September 25, 2009</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Clinical Evaluation Research Unit at Kingston General Hospital</investigator_affiliation>
    <investigator_full_name>Daren K. Heyland</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Randomized Clinical Trial</keyword>
  <keyword>Glutamine</keyword>
  <keyword>Themal Burn Injuries</keyword>
  <keyword>Nutrition</keyword>
  <keyword>Outcome Assessment</keyword>
  <keyword>Critical Care</keyword>
  <keyword>Total Burn Surface Area</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
